PEDONE, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 11.221
NA - Nord America 6.768
EU - Europa 2.278
SA - Sud America 878
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 43
Totale 21.413
Nazione #
SG - Singapore 7.348
US - Stati Uniti d'America 6.486
CN - Cina 1.596
HK - Hong Kong 1.201
IT - Italia 1.042
BR - Brasile 595
GB - Regno Unito 414
VN - Vietnam 346
FR - Francia 303
BD - Bangladesh 198
CA - Canada 148
IN - India 138
DE - Germania 137
AR - Argentina 81
ID - Indonesia 66
MX - Messico 61
NL - Olanda 60
CO - Colombia 56
EC - Ecuador 55
ES - Italia 47
ZA - Sudafrica 47
TR - Turchia 44
PL - Polonia 41
AU - Australia 39
UA - Ucraina 35
FI - Finlandia 33
PH - Filippine 32
VE - Venezuela 32
MY - Malesia 31
JP - Giappone 29
IQ - Iraq 28
PK - Pakistan 25
SA - Arabia Saudita 23
IR - Iran 19
CL - Cile 17
CR - Costa Rica 17
MA - Marocco 17
RU - Federazione Russa 16
LT - Lituania 15
SE - Svezia 15
CZ - Repubblica Ceca 13
BG - Bulgaria 12
NP - Nepal 12
RS - Serbia 12
TN - Tunisia 12
KZ - Kazakistan 11
MD - Moldavia 11
PY - Paraguay 11
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
UY - Uruguay 10
JM - Giamaica 9
TH - Thailandia 9
IL - Israele 8
AT - Austria 7
BO - Bolivia 7
EE - Estonia 7
IE - Irlanda 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
AL - Albania 5
DZ - Algeria 5
KR - Corea 5
NI - Nicaragua 5
PA - Panama 5
PR - Porto Rico 5
UZ - Uzbekistan 5
AM - Armenia 4
AZ - Azerbaigian 4
KY - Cayman, isole 4
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
JO - Giordania 3
KH - Cambogia 3
LU - Lussemburgo 3
LY - Libia 3
MK - Macedonia 3
PS - Palestinian Territory 3
SN - Senegal 3
TJ - Tagikistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CM - Camerun 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
Totale 21.273
Città #
San Jose 1.703
Ashburn 1.208
Hong Kong 1.197
Singapore 1.089
Rome 721
Hefei 596
Council Bluffs 388
London 348
Boardman 347
Columbus 309
Beijing 275
Lauterbourg 246
Dallas 242
Shanghai 207
Santa Clara 134
Los Angeles 127
Ho Chi Minh City 118
New York 113
San Francisco 87
Hanoi 83
Phoenix 56
São Paulo 53
Munich 47
Pune 42
Toronto 42
Orem 41
Washington 39
Chicago 37
Seattle 37
Atlanta 35
Brooklyn 33
Montreal 32
Mexico City 30
Warsaw 30
Boston 29
Milan 29
Rio de Janeiro 29
Amsterdam 27
West Jordan 26
Buffalo 23
Denver 22
Turku 21
Guayaquil 20
Haiphong 20
Johannesburg 20
Da Nang 19
Tokyo 19
Guangzhou 18
Canberra 17
Houston 17
Charlotte 16
Chennai 16
Las Vegas 16
Quito 16
Biên Hòa 15
Bogotá 15
Paris 15
Frankfurt am Main 14
Manchester 14
Philadelphia 14
San José 13
Melbourne 12
The Dalles 12
Calgary 11
Caracas 11
Helsinki 11
Kuala Lumpur 11
Lahore 11
Porto Alegre 11
Riyadh 11
Baghdad 10
Dhaka 10
Stockholm 10
Ankara 9
Bari 9
Belgrade 9
Belo Horizonte 9
Bologna 9
Brasília 9
Florence 9
Memphis 9
Montevideo 9
Mumbai 9
Pittsburgh 9
Salvador 9
Shenzhen 9
Zhengzhou 9
Brno 8
Louisville 8
Markham 8
Medellín 8
Nairobi 8
Turin 8
Curitiba 7
Lima 7
Madrid 7
Miami 7
Naples 7
Nuremberg 7
Perugia 7
Totale 10.966
Nome #
Is Citicoline Effective in Preventing and Slowing Down Dementia?—A Systematic Review and a Meta-Analysis 865
A decision support system for tele-monitoring copd-related worrisome events 278
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in Hyperparathyroidism 271
Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey 242
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 240
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 238
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 237
Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism 230
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD 227
Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing 223
Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes 222
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 219
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study 219
Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19 217
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 210
A rare cause of chronic diarrhoea in an elderly patient 207
Asthma in the elderly: mortality rate and associated risk factors for mortality 188
Treating COPD in Older and oldest old Patientsp 185
Predictors of undernutrition in COPD patients 182
Non-invasive ventilation in octuagenarians out of the intensive care unit: Tolerability, efficacy and safety results 177
Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease 177
"Cardiovascular dementia" reappraisal of an old concept and Giambattista Vico's course and recourse theory: is history repeating itself? 161
25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study 159
Accuracy of spirometry in diagnosing pulmonary restriction in elderly people 156
CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION 155
Ageing and COPD affect different domains of nutritional status: the ECCE study 153
Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon 150
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 149
Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System 148
BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes 142
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference? 142
Association of reduced total lung capacity with mortality and use of health services 140
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial 138
CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM 134
Adiponectin and bone mass density The InCHIANTI study 133
BODE index or geriatric multidimensional assessment for the prediction of very-long-term mortality in elderly patients with chronic obstructive pulmonary disease? A prospective cohort study 133
Agreement between Chronic Kidney Disease Epidemiological Collaboration and Berlin Initiative Study equations for estimating glomerular filtration rate in older people: The Invecchiare in Chianti (Aging in Chianti Region) study 132
Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma 130
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 128
Age does not hamper the response to pulmonary rehabilitation of COPD patients 127
Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency 125
Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism 124
The Oxygen therapy 121
Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism 119
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 119
Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) 119
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 118
Pre-polysomnographic assessment using the Pittsburgh Sleep Quality Index questionnaire is not useful in identifying people at higher risk for obstructive sleep apnea 117
Effects of different masks on diaphragm motion in OSAS patients undergoing CPAP: results from an ultrasound-based proof of concept study 116
Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism 111
Association between frailty index, lung function, and major clinical determinants in chronic obstructive pulmonary disease 108
Genetic background of idiopathic pulmonary fibrosis 108
Risk Factors for Fragility Fractures in Type 1 Diabetes 106
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength 105
Noninvasive ventilation in older adults admitted to a pneumogeriatric unit 104
Use of Plant-Derived Natural Products in Sleep Disturbances 102
Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices 99
Patients with migraine with aura have increased flow mediated dilation 98
Is it time to use pre-bronchodilator spirometry to rule out COPD? 97
Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE 96
Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions 93
Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA) 92
Curcumin use in pulmonary diseases: State of the art and future perspectives 74
Utility of an electronic nose in discriminating obstructive sleep apnea and COPD by breath fingerprints analysis 72
PTH(1-34) for the primary prevention of postthyroidectomy hypocalcemia: The THYPOS trial 71
Nursing student attitudes towards older people: validity and reliability of the Italian version of the Kogan Attitudes towards Older People scale 70
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 70
Comorbidity modulates non invasive ventilation-induced changes in breath print of obstructive sleep apnea syndrome patients 68
Correlates of mortality in elderly COPD patients: focus on health related quality of life 68
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 67
Effect of insulin resistance on BMD and fracture risk in older adults 67
Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial 67
Association between PUFA intake and serum concentration and mortality in older adults: A cohort study 67
PTH(1-34) for surgical hypoparathyroidism: A 2-year prospective, open-label investigation of efficacy and quality of life 67
Non-invasive monitoring of lower-limb ulcers via exudate fingerprinting using BIONOTE 67
Chronic renal failure: a neglected comorbidity of COPD 66
Validation of FEV6 in the elderly: correlates of performance and repeatability 66
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 65
Integration of voltammetric analysis, protein electrophoresis and pH measurement for diagnosis of pleural effusions: a non-conventional diagnostic approach 65
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 65
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 64
Chronic obstructive pulmonary disease in the elderly 63
On the remote detection of COPD-related worrisome events 63
Clusters of functional domains to identify older persons at risk of disability 63
Exhaled breath analysis by electronic nose in respiratory diseases 63
Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. 62
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 62
Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women 61
Nutritional status is associated with physical function and disability in older adults with chronic heart failure 61
Association between sodium excretion and cardiovascular disease and mortality in the elderly: a cohort study 61
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study) 61
Cardiac amyloidosis awareness among residents/specialists in geriatrics: An italian national survey 60
GOLD and the fixed ratio Response 60
Hemoglobin concentration influences N-terminal Pro B-type natriuretic peptide levels in hospitalized older adults with and without heart failure 60
Voltammetric analysis for fast and inexpensive diagnosis of urinary tract infection: a diagnostic study 59
Predicting survival of older community-dwelling individuals according to five estimated glomerular filtration rate equations: The InChianti study 59
Body mass index and mortality among hospitalized patients 59
Health status in older hospitalized patients with cancer or non-neoplastic chronic diseases 59
Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study 59
Prognostic value of FEV1/FEV6 in elderly people 59
Totale 12.801
Categoria #
all - tutte 155.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022373 0 0 17 0 10 1 2 9 12 8 5 309
2022/2023147 15 5 3 7 7 7 15 5 5 3 75 0
2023/20241.074 45 127 36 83 111 455 11 51 37 37 44 37
2024/20258.654 150 101 385 55 79 237 132 46 815 742 2.667 3.245
2025/20268.987 853 341 514 1.027 343 541 2.383 730 745 778 354 378
2026/20272.173 411 1.241 521 0 0 0 0 0 0 0 0 0
Totale 21.413